Cosmo Pharmaceuticals N.V. (ETR:C43)

Germany flag Germany · Delayed Price · Currency is EUR
50.00
0.00 (0.00%)
Inactive · Last trade price on Apr 30, 2025
-31.97%
Market Cap 826.85M
Revenue (ttm) 266.79M
Net Income (ttm) 133.24M
Shares Out n/a
EPS (ttm) 8.12
PE Ratio 6.21
Forward PE n/a
Dividend 2.05 (3.94%)
Ex-Dividend Date Jun 4, 2025
Volume n/a
Average Volume 65
Open 50.00
Previous Close n/a
Day's Range 50.00 - 50.00
52-Week Range 47.80 - 86.50
Beta n/a
RSI 34.20
Earnings Date Jul 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Deutsche Börse Xetra
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.